As the most common driver events in GH-secreting tumors, GNAS mutations occur in up to 40% acromegaly patients (4), and this rate varies from 4.4% (Japanese, 1993) (20) to 59.5% (Korean, 2021) (6) in different research studies. Here, GNAS is linked to acromegaly.